Asklepios Kliniken

EQS-News: Asklepios Group: Sound business performance in first nine months of 2023

Retrieved on: 
Thursday, December 14, 2023
EAT, Food, EUR, CFO, Hospital, Patient, Exercise, Asklepios Kliniken, Environment, Asclepius, Nursing, Lithium

Asklepios Kliniken GmbH & Co. KGaA recorded sound business performance in the first nine months of 2023.

Key Points: 
  • Asklepios Kliniken GmbH & Co. KGaA recorded sound business performance in the first nine months of 2023.
  • Important aspects of the hospital reform, such as hospital funding and combating the shortage of specialist staff, have not yet been clarified.
  • “Asklepios has achieved sound business performance despite the challenging environment.
  • Despite the uncertain market environment, Asklepios Kliniken is aiming for a sustainable overall improvement in operating earnings in 2023 as a whole.

EQS-News: Asklepios Kliniken: Stable development in H1 2023 despite challenging market environment

Retrieved on: 
Thursday, August 24, 2023
Food, Asklepios Kliniken, Federal Deposit Insurance Corporation, Asclepius, EUR, Hospital, Patient, EAT, CFO, Private, Pharmaceutical industry, Health care

Asklepios Kliniken GmbH & Co. KGaA recorded stable development in the first half of 2023 in a challenging market environment.

Key Points: 
  • Asklepios Kliniken GmbH & Co. KGaA recorded stable development in the first half of 2023 in a challenging market environment.
  • In the first six months of 2023, a total of 1,708,321 patients were treated at Asklepios Kliniken healthcare facilities (6M 2022: 1,749,734).
  • In the first six months of 2023, the Asklepios Group generated consolidated revenue of EUR 2,708.4 million (6M 2022: EUR 2,608.9 million), representing revenue growth of 3.8%.
  • Asklepios currently also expects the second half of 2023 to be challenging.

DGAP-News: Asklepios Kliniken: Stable development continues in H1 2022

Retrieved on: 
Thursday, August 25, 2022
CEO, EBITDA, EBIT, Coronavirus, IFRS, Nursing, Investment, Hospital, Social responsibility, CFO, Asclepius, EAT, Group, Risk, Asklepios Kliniken, Automation, Patient, Renewable energy, Lithium, Health insurance

Asklepios Kliniken GmbH & Co. KGaA has closed the first half of 2022 with a stable development of consolidated revenue and consolidated net operating income (EAT).

Key Points: 
  • Asklepios Kliniken GmbH & Co. KGaA has closed the first half of 2022 with a stable development of consolidated revenue and consolidated net operating income (EAT).
  • From January to June 2022, Asklepios Kliniken treated a total of 1,749,734 patients (6M 2021: 1,447,999) in its healthcare facilities.
  • This is also reflected in our stable revenue growth, says Kai Hankeln, CEO of Asklepios Kliniken.
  • The Asklepios Groups financial position was stable at the end of the first half of 2022.

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG closes first nine months of 2021 with increase in revenues

Retrieved on: 
Thursday, November 11, 2021
Asklepios Kliniken, Nursing, University, Tax, Person, News, Disease, National Association Medical Staff Services, Depreciation, COVID-19, EV/Ebitda, Policy, Asclepius, Optimism, EBITDA, Partnership, Board, Hospital, Company, Infection, FDP, Corona, SPD, Patient, Magazine, DGAP, Security (finance), Pharmaceutical industry, Health insurance

In the first nine months of financial year 2021, the Group of RHN-KLINIKUM AG recorded revenues of 1,030.6 million after 1,018.7 million in the same period of the previous year, an increase of 1.2%.

Key Points: 
  • In the first nine months of financial year 2021, the Group of RHN-KLINIKUM AG recorded revenues of 1,030.6 million after 1,018.7 million in the same period of the previous year, an increase of 1.2%.
  • Over the past months, RHN-KLINIKUM AG's efforts to cope with the COVID-19 pandemic have continued undiminished.
  • The forecast for revenues for financial year 2021 of 1.4 billion within a range of +/ 5% is maintained.
  • www.rhoen-klinikum-ag.com
    RHN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale
    11.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.

DGAP-News: Asklepios Kliniken: COVID-19 pandemic impacting first quarter of 2021

Retrieved on: 
Thursday, May 27, 2021
Asklepios Kliniken

The ongoing coronavirus pandemic continued to have a significant influence on the performance of Asklepios Kliniken GmbH & Co. KGaA in the first quarter of 2021 as well.

Key Points: 
  • The ongoing coronavirus pandemic continued to have a significant influence on the performance of Asklepios Kliniken GmbH & Co. KGaA in the first quarter of 2021 as well.
  • Asklepios (not including Rhn) reported a decrease of around 20% in the number of inpatient treatments compared with the same quarter of the previous year.
  • The revenue of the Asklepios hospitals amounted to EUR 1,221.0 million in the first quarter of 2021 (3M 2020: EUR 915.0 million).
  • Asklepios (including Rhn) made total investments of EUR 76.4 million in the first quarter of 2021 (3M 2020, not including Rhn: EUR 62.6 million).

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft: First quarter of 2021 continues to be marked by COVID-19 pandemic

Retrieved on: 
Thursday, May 6, 2021
Asklepios Kliniken, Gesellschaft mit beschränkter Haftung, Articles, Law

b'The issuer is solely responsible for the content of this announcement.\nThe first quarter of financial year 2021 of RH\xc3\x96N-KLINIKUM AG continued to be dominated by the COVID-19 pandemic.

Key Points: 
  • b'The issuer is solely responsible for the content of this announcement.\nThe first quarter of financial year 2021 of RH\xc3\x96N-KLINIKUM AG continued to be dominated by the COVID-19 pandemic.
  • The trend towards the normalisation of patient numbers was brought to an end by the third wave of the pandemic.
  • Parallel to that, new provisions on minimum staffing levels have significantly reduced the number of available hospital beds, purely in terms of calculations.
  • RH\xc3\x96N-KLINIKUM AG is an independent company under the roof of Asklepios Kliniken GmbH & C. KGaA.

DGAP-News: Asklepios Group: 2020 financial year dominated by COVID-19 pandemic and Rhön acquisition

Retrieved on: 
Thursday, April 29, 2021
Asklepios Kliniken

The year 2020 brought enormous challenges for the Asklepios Group, as for the entire healthcare sector in Germany.

Key Points: 
  • The year 2020 brought enormous challenges for the Asklepios Group, as for the entire healthcare sector in Germany.
  • "\nDespite this challenging situation, Asklepios Kliniken GmbH & Co. KGaA completed the acquisition and integration of Rh\xc3\xb6n-Klinikum AG.
  • Even during the pandemic, Asklepios implemented planned investments of EUR 389.5 million (2019: EUR 325.8 million) in the medical area.
  • In the 2020 financial year, over 2.6 million patients were treated at the Asklepios Group\'s facilities.

DGAP-News: Asklepios successfully issues Schuldschein loan agreement worth EUR 730 million

Retrieved on: 
Wednesday, October 28, 2020
Asklepios Kliniken

Asklepios Kliniken GmbH & Co. KGaA has successfully placed a Schuldschein loan agreement worth EUR 730 million on the market.

Key Points: 
  • Asklepios Kliniken GmbH & Co. KGaA has successfully placed a Schuldschein loan agreement worth EUR 730 million on the market.
  • Due to high demand, the transaction was oversubscribed several times over and the original target volume of EUR 200 million was increased significantly.
  • The placement is thus one of the biggest transactions on the Schuldschein market so far this year.
  • As the markets then thawed, we seized the opportunity to bring a relatively large Schuldschein loan agreement onto the market," says Hafid Rifi, CFO of the Asklepios Group.

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft sells shares in Medgate Deutschland GmbH

Retrieved on: 
Friday, September 25, 2020
Asklepios Kliniken, Gesellschaft mit beschränkter Haftung, Articles, Law

co-shareholder, Medgate Holding AG.

Key Points: 
  • co-shareholder, Medgate Holding AG.
  • At the same time, the shareholders of Medgate Deutschland GmbH have also agreed that such fundamental cooperation is not dependent on the rigid boundaries of a legal entity.
  • As a result, Medgate Deutschland GmbH in future will exclusively belong to the Medgate Holding AG group.
  • RHN-KLINIKUM AG is an independent Company operating under the umbrella of Asklepios Kliniken GmbH & Co. KGaA.

DGAP-News: Asklepios Kliniken posts sound development in operating business in first half of 2020 despite coronavirus

Retrieved on: 
Thursday, August 27, 2020
Articles, Health, Occupational safety and health, Asklepios Kliniken, COVID-19 pandemic, Coronavirus disease, Pandemic

In the first half of 2020, Asklepios Kliniken GmbH & Co. KGaA felt the effects of the COVID-19 pandemic, but to a lesser extent than many other companies in the healthcare sector.

Key Points: 
  • In the first half of 2020, Asklepios Kliniken GmbH & Co. KGaA felt the effects of the COVID-19 pandemic, but to a lesser extent than many other companies in the healthcare sector.
  • As expected, numbers decreased in both inpatient and outpatient care as a result of the coronavirus pandemic.
  • Since the number of new coronavirus infections has stabilised below critical levels, Asklepios has been vehemently advocating a return to regular operations in hospitals.
  • In the first half of 2020, the company's total investment including subsidies came to EUR 138.2 million (6M 2019: EUR 126.0 million).